Tag: the war on (some) drugs

Medical Marijuana Has ‘Promising Results’ For Fibromyalgia Patients, New Study Shows

Marijuana is useful in treating pain and other symptoms related to fibromyalgia, a new study shows—with authors reporting pain relief, improved sleep and better quality of life in patients who vaporized THC-rich cannabis.

Researchers behind the new case series concluded that “cannabinoids treatment showed promising results in the management of chronic pain and other FM [fibromyalgia]-associated symptoms, improving the quality of life of these patients,” though they acknowledged the need for further study given the limited nature of their initial observations.

The research, published in the Journal of Alternative Complementary and Integrative Medicine, looks at the impact of cannabis treatment on three patients in Portugal who used an 18-percent THC cannabis flower product. The product, from the Canadian producer Tilray, is “the only commercially available medical cannabis product in Portugal,” the study notes.

In addition to reductions in pain and improvements in sleep quality—seen in all three subjects—two of the patients also reported decreases in other medication they were seeing, suggesting a substitution effect.

Keep reading

We Need Medical Freedom

In a free society, people have the right to decide what to do with their own bodies. If you want to take something that “orthodox” medicine says you shouldn’t, this decision should be up to you. If the government can ban “dangerous drugs,” why not dangerous ideas too? As the great Ludwig von Mises points out, “Opium and morphine are certainly dangerous, habit-forming drugs. But once the principle is admitted that it is the duty of government to protect the individual against his own foolishness, no serious objections can be advanced against further encroachments. A good case could be made out in favor of the prohibition of alcohol and nicotine. And why limit the government’s benevolent providence to the protection of the individual’s body only? Is not the harm a man can inflict on his mind and soul even more disastrous than any bodily evils? Why not prevent him from reading bad books and seeing bad plays, from looking at bad paintings and statues and from hearing bad music? The mischief done by bad ideologies, surely, is much more pernicious, both for the individual and for the whole society, than that done by narcotic drugs.

Keep reading

California Governor Unveils Emergency Ban On Hemp Products With THC

California Gov. Gavin Newsom last week proposed an emergency ban on intoxicating hemp products, saying the new regulations are needed to protect the safety of children. The governor issued the proposed emergency regulations, which prohibit sales of consumable hemp products that contain intoxicating cannabinoids including THC after they were drafted by the California Department of Public Health (CDPH).

“We will not sit on our hands as drug peddlers target our children with dangerous and unregulated hemp products containing THC at our retail stores,” Newsom said in a September 6 statement. “We’re taking action to close loopholes and increase enforcement to prevent children from accessing these dangerous hemp and cannabis products.”

Keep reading

Dem House candidate pushes tough on fentanyl stance after dismissing it as border issue

Democratic congressional candidate Monica Tranel appears to be changing her tune on the fentanyl crisis this cycle after previously suggesting that the deadly drug was not coming from the southern border.

Tranel, the Democratic candidate running in Montana’s First Congressional District against Republican incumbent Rep. Ryan Zinke, recently released a campaign ad appearing tough on the border.

However, during her first congressional bid in 2022, Tranel claimed that the border crisis is unrelated to fentanyl trafficking while debating Zinke at the City Club Missoula.

“It is a significant issue where we are, but where it is coming from is not the southern border,” Tranel said of fentanyl during the debate. “It’s being made in China, and how it’s getting here is a complex series of things that are happening, and shutting down the border is not going to reduce the fentanyl crisis.”

Keep reading

New Jersey Governor Signs Controversial Bill Restricting Sales Of Hemp Cannabinoid Products

New Jersey businesses are temporarily banned from selling hemp products without a cannabis license under a controversial bill Gov. Phil Murphy (D) signed into law Thursday, a response to years of complaints about legal loopholes that allow minors to buy sketchy hemp products.

The measure will put hemp products, which are federally legal, under the purview of the state’s Cannabis Regulatory Commission, the agency that oversees New Jersey’s recreational and medicinal marijuana markets.

In a signing statement, Murphy called the bill flawed, but said in the two-and-a-half months since the bill landed on his desk, he’s held discussions with supporters and critics that convinced him it’s “very unlikely that revisions to the bill would have the broad support necessary to move through the Legislature quickly.”

“Unlike many issues, the status quo poses an immediate risk to health and safety, as these unregulated intoxicating hemp products are widely available to minors. Because the bill would address this present danger, I have concluded that the wiser course is to sign the bill now and commit to working with the Legislature to address the technical issues and other challenges in separate legislation,” he said in the statement.

Congress legalized hemp in 2018, but with little regulation, testing or enforcement, intoxicating products have been spotted on shelves of corner stores and gas stations. Lawmakers moved to pass the bill amid concerns that children are buying products advertised with thousands of milligrams of THC.

Hemp products have a lower form of THC than cannabis, and they do not get users high in the same way marijuana products with delta-9 THC (the kind someone would buy at a cannabis dispensary).

Under the new law, it’s illegal to sell products with any detectable amount of THC to a person under 21 years of age. And within 30 days, businesses will have to pull any hemp products off their shelves until the cannabis commission establishes new rules regarding sales.

The bill—amended with last-minute changes—elicited “significant concerns” from the cannabis and hemp industries, Murphy noted. Wording in the bill has created confusion, specifically the definition of hemp product as “any product cultivated, derived, or manufactured in this state from hemp,” Murphy said.

That language could either allow businesses to sell hemp products made outside of New Jersey without violating the law, or limit sales to those products made exclusively in New Jersey, Murphy said, noting the former would largely defeat the purpose of the bill by creating “an enormous loophole,” while the latter could violate the Constitution’s dormant commerce clause.

The bill’s supporters applauded the long-awaited signing.

Keep reading

Nixon Admitted Marijuana Is ‘Not Particularly Dangerous’ In Newly Discovered Recording

Former President Richard Nixon, despite declaring the war on drugs and rejecting a federal commission’s recommendation to decriminalize marijuana, admitted in a newly unearthed recording that he knew cannabis is “not particularly dangerous.”

“Let me say, I know nothing about marijuana,” Nixon said in a March 1973 White House meeting. “I know that it’s not particularly dangerous, in other words, and most of the kids are for legalizing it. But on the other hand, it’s the wrong signal at this time.”

“The penalties should be commensurate with the crime,” Nixon said, arguing that a 30-year sentence in a cannabis case he recently heard about was “ridiculous.”

“I have no problem that there should be an evaluation of penalties on it, and there should not be penalties that, you know, like in Texas that people get 10 years for marijuana. That’s wrong,” the president said.

The comments, first reported by the New York Times, come as the federal government is reconsidering marijuana’s status as a restricted Schedule I drug.

The Department of Health and Human Services, after conducting a review initiated by President Joe Biden, recommended last year that cannabis should be moved to Schedule III. The Department of Justice agreed, publishing a proposed rescheduling rule in the Federal Register in May.

The Drug Enforcement Administration (DEA), however, has expressed hesitation about enacting the reform, however, and has scheduled a public hearing on the cannabis rescheduling matter for December 2, after the upcoming presidential election.

Nixon’s admission in the newly revealed tapes that marijuana is “not particularly dangerous” runs in contrast to his image as a drug warrior and undermines his and subsequent administrations’ decisions to classify it in Schedule I of the Controlled Substances Act, which is supposed to be reserved for substances with a high potential for abuse and no accepted medical value.

Keep reading

Hemp And CBD Groups Threaten To Sue California Over Governor’s New Rules Restricting Cannabinoid Products

California Gov. Gavin Newsom’s (D) plan to crack down on hemp-derived cannabinoids in the state is rankling some in hemp industry, who now say they’re exploring lawsuits to challenge the governor’s proposed emergency rules unveiled last week.

On Friday, the advocacy group One Hemp said it’s considering a court challenge “with the intent to hold Newsom accountable to the normal democratic process.”

The organization, which has ties to the hemp CBD industry, notes the governor’s proposal was never approved by the state legislature and would severely restrict access to hemp products already legal under federal law.

“These are products that the disabled, chronically ill and veteran communities cannot live without to help support seizures, pain and mobility management, sleep and more,” One Hemp said in a press release about the possible lawsuit.

Jared Stanley, a founding member of One Hemp and a co-founder of the CBD company Charlotte’s Web, said Newsom’s plan to target hemp-derived cannabinoids is overbroad and would severely harm families who rely on CBD products.

Keep reading

Psychedelic mushrooms may have played a role in development of human consciousness, study finds

Psychedelic fungi containing psilocybin may have played a role in the development of human consciousness a scientific review has suggested.

The study, published in the journal LILLOA, analysed multiple studies involving psilocybin, psilocin and human consciousness. Taking a multidisciplinary approach spanning studies from the fields of biology, ethnobotany, and neuroscience researchers found that psychedelic mushrooms, specifically the Psilocybe genus of the Hymenogastraceae family, had the “potential to trigger significant neurological and psychological effects” in humans.

The findings support the Stoned Ape Theory, a hypothesis proposed by ethnobotanist Terence McKenna in his 1992 book Food of the Gods. McKenna suggested that psychedelic mushrooms were the major evolutionary catalyst behind the rapid expansion of human consciousness.

“At the cerebral level, psilocybin affects various areas, such as the prefrontal cortex, the hippocampus, and the anterior cingulate cortex,” the study authors wrote. “The hypothesis that psilocybin mushrooms may have intervened as a factor in the evolution of human consciousness, either as catalysts for mystical experiences or as drivers of cognitive processes, raises profound reflections on the ancestral interaction between humans and their environment.”

The paper highlights how numerous ancient cultures across the world discovered and studied psilocybin-containing mushrooms, citing a prehistoric cave drawing of a shaman figure clutching mushrooms found in the Tassili caves in the Altas Mountains. This suggests, the authors said, that psychedelic mushrooms have played an important part in the evolutionary process of humans.

Keep reading

Thousands Flock To Tribal Marijuana Store In North Carolina, Where Cannabis Is Otherwise Illegal, For Launch Of Adult-Use Sales

More than 4,000 of people lined up at The Great Smoky Cannabis Co. this past weekend as the tribal marijuana retailer began the first-ever legal adult-use cannabis sales within North Carolina.

Michell Hicks, principal chief of the Eastern Band of Cherokee Indians (EBCI), which voted a year ago to legalize adult-use cannabis on its 57,000-acre Qualla Boundary, called the launch “a significant milestone for our tribe, marking a new chapter of opportunity and growth.”

“This initiative is our right as a Tribal government to assert our Sovereignty,” he wrote.

“I want to take a moment to personally acknowledge and thank everyone who has poured their hard work, time, and passion into making this day possible,” he said. “Your dedication has been instrumental in bringing this vision to life, and I’m confident that this is just the beginning.”

Sales began at 10 a.m. local time on Saturday, with any adult 21 and older eligible to buy marijuana products.

“It’s a special day for us,” Forrest Parker, general manager for Qualla Enterprises, which operates Great Smoky Cannabis Co., told the tribe’s newspaper, Cherokee One Feather. “It’s a special day for the Eastern Band of Cherokees, period.”

Videos posted to social media on opening day Saturday showed a long line of cars waiting to take advantage of the dispensary’s drive-thru.

“When you see the people in this line, it’s clear,” Parker said. “And it’s very validating, I think, to the plant and to the medicine that comes from the ground. Which, nobody understands that more than Indigenous people.”

Great Smoky Cannabis began selling medical marijuana on April 20 of this year. In July, the store began recreational sales, but only to members of EBCI and other federally recognized Indian tribes. Saturday marked the first time any adult 21 and older could purchase cannabis from the store.

Speaking to local reporters on Monday, Parker said the opening was “humbling” and that he expects even more activity as momentum builds.

Keep reading

Federal Officials Say Psychedelic-Assisted Therapy Shows Promise For PTSD, But More Research Is Needed

Representatives of a number of federal agencies convened last week to discuss new treatments for PTSD, including therapies involving psychedelics, MDMA, ketamine and other drugs. While the officials acknowledged the substances’ potential to help treat PTSD and underlying symptoms, they also emphasized the need for further research to ensure efficacy and patient safety.

The discussion, hosted by the Reagan-Udall Foundation for the Food and Drug Administration, a nonprofit formed by Congress to support FDA, didn’t focus specifically on psychedelic-assisted therapies, but the topic nevertheless featured prominently—especially during a stakeholder comment session where most spoke in favor of wider access to MDMA and other emerging treatments.

Betty Aldworth, director of communications and post-prohibition strategy for the Multidisciplinary Association for Psychedelic Studies (MAPS)—which has helped lead the push to qualify MDMA as a federally approved treatment for PTSD—said the meeting “illustrated the growing public interest in psychedelic-assisted therapies, with nearly every speaker discussing their potential in a meeting that wasn’t specifically about psychedelics.”

“Eighty members of Congress, the Veterans Affairs Administration, trauma experts, patient advocates, and 14 of 23 stakeholder who gave oral testimony agree the existing evidence base for psychedelic-assisted therapies merit widespread, and growing, support,” Aldworth said in a statement after the event. “It’s time to close the 25-year gap on new pharmacotherapies for the treatment of PTSD by approving this most promising treatment for PTSD and bringing psychedelic-assisted therapies into the healthcare system.”

Speakers at the Reagan-Udall event on Friday included representatives from the Department of Defense, Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Substance Abuse and Mental Health Services Administration (SAMHSA) and Department of Veterans Affairs (VA).

Keep reading